Organon & Co
OGN
13.79
+0.05
+0.36%
Organon & Co
US · OGN
#2364 by market cap
Listed 1970
13.79
+0.05
+0.36%
Live - 5344 symbols - heartbeat 278s ago
· 2026-10-08 08:26
Pre-market
13.79
0.00%
After-hours
13.79
0.00%
- Market cap
- 3.62B
- P/E (TTM)i
- 17.68
- P/Bi
- 3.60
- EPSi
- 0.72
- Div yieldi
- 0.58%
- 52W posi
- 100%
Reader sentiment
Are you bullish or bearish on OGN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.2 percentage points.
Institutional ownership
- Held by institutions
- 83.83% -0.20pp
- Institutions
- 703 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund54.87%
Hedge Fund22.73%
Public Company3.22%
Government Pension Fund1.85%
Individual/Insider0.49%
Private Company0.45%
Family Office/Trust0.22%
Corporate Pension Plan0.15%
Sovereign Wealth Fund0.15%
Other15.86%
Top holders as of 2026-06-30
BlackRock
12.21% · 32.06M sh
Pentwater Capital Management LP
6.89% · 18.10M sh
Vanguard Portfolio Management, LLC
5.76% · 15.13M sh
Vanguard Capital Management, LLC
5.17% · 13.57M sh
State Street Global Advisors
3.68% · 9.66M sh
UBS Asset Management
2.13% · 5.60M sh
AQR Capital Management
1.95% · 5.12M sh
Geode Capital Management, LLC
1.83% · 4.82M sh
AllianceBernstein
1.81% · 4.75M sh
The Goldman Sachs Group, Inc.
1.74% · 4.57M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 34 buys · 16 sells
| Name | Role | Stake |
|---|---|---|
| Kevin Ali | Chief Executive Officer | 0.11% |
| Matthew Walsh | Chief Financial Officer | 0.08% |
| Joseph Morrissey | Executive VP and Head of Manufacturing & Supply | 0.05% |
| Rachel Stahler | Executive Vice President | 0.04% |
| Aaron Falcione | Executive Vice President | 0.04% |
| Kirke Weaver | General Counsel | 0.04% |
| Carrie Cox | Independent Chairperson | 0.03% |
| Vittorio Nisita | Executive VP & Head of Global Business Services | 0.03% |
| Daniel Karp | Chief Business Development Officer | 0.03% |
| Susanne Fiedler | Executive Vice President | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-10 | Juan Camilo Ferreira | Chief Medical Officer | Derivative Exercise and Sale | -4,134 | $13.62 |
| 2026-08-10 | Juan Camilo Ferreira | Chief Medical Officer | Derivative Exercise and Retained | +7,385 | -- |
| 2026-08-04 | Juliana Drinane | Head of Supply Chain Management | Open Market Disposition | -14,761 | $13.57 |
| 2026-06-11 | Robert Essner | Independent Director | Other Derivative Acquisition | +17,857 | -- |
| 2026-06-11 | Rochelle Lazarus | Independent Director | Other Derivative Acquisition | +17,857 | -- |
| 2026-06-11 | R. Alan Ezekowitz | Independent Director | Other Derivative Acquisition | +17,857 | -- |
| 2026-06-11 | Helene Gayle | Independent Director | Other Derivative Acquisition | +17,857 | -- |
| 2026-06-11 | Shalini Sharp | Independent Director | Other Derivative Acquisition | +17,857 | -- |
| 2026-06-11 | Philip Ozuah | Independent Director | Other Derivative Acquisition | +17,857 | -- |
| 2026-06-11 | Cynthia Patton | Independent Director | Other Derivative Acquisition | +17,857 | -- |
| 2026-06-11 | Ramona Sequeira | Director | Other Derivative Acquisition | +17,857 | -- |
| 2026-06-11 | Deborah Leone | Independent Director | Other Derivative Acquisition | +17,857 | -- |
| 2026-05-05 | Holzbaur Lynette | Senior VP of Finance & Corporate Controller | Other Acquisition | +45 | -- |
| 2026-05-05 | Holzbaur Lynette | Senior VP of Finance & Corporate Controller | Open Market Disposition | -26,448 | $13.35 |
| 2026-03-30 | Matthew Walsh | Chief Financial Officer | Derivative Exercise and Sale | -11,507 | $5.70 |
| 2026-03-30 | Matthew Walsh | Chief Financial Officer | Other Derivative Acquisition | +404,840 | -- |
| 2026-03-30 | Matthew Walsh | Chief Financial Officer | Derivative Exercise and Retained | +22,086 | -- |
| 2026-03-30 | Rachel Stahler | Executive Vice President | Derivative Exercise and Sale | -6,463 | $5.70 |
| 2026-03-30 | Rachel Stahler | Executive Vice President | Other Derivative Acquisition | +183,639 | -- |
| 2026-03-30 | Rachel Stahler | Executive Vice President | Derivative Exercise and Retained | +12,404 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:26:54 · For reference only, not investment advice and not tailored to your situation.